Your browser does not support JavaScript!
Logo de ABBOTT

ABBOTT

ABBOTT
Discussion avec ABBOTT

Bonjour, Comment puis-je vous aider ?

Envoyer
01 45 60 25 00
Contacter l'entreprise

À propos

Recherche, développement et commercialisation de réactifs et de systèmes d'analyses médicales. Production et d

Site web et réseaux sociaux

http://www.abbott.fr
Une actualité de FierceBiotech où est cité ABBOTT
Il y a 6 jours

ADA: Real-world data show lower A1c levels with Abbott's FreeStyle Libre CGM in Type 2 diabetes

Il y a 1 semaine
In its first evaluation of real-world data derived from its FreeStyle Libre continuous glucose monitor in people with Type 2 diabetes, Abbott found that the system was able to significantly reduce...
www.fiercebiotech.com
Une actualité de FierceBiotech où est cité ABBOTT
Le 07/05/2019

Abbott smartens up its smartphone-based ICM with more accurate detection

Le 06/05/2019
Abbott has launched a new, smarter version of its small implantable monitor for detecting irregular heartbeats that the company says now reduces the rate of false detection by 97%....
www.fiercebiotech.com
Une actualité de FierceBiotech où est cité ABBOTT
Le 25/02/2019

DOJ joins 5-year-old false claim and kickback suit against Abbott’s Alere acquisition

Le 22/02/2019
The legal headaches continue for Abbott following its 2017 roller-coaster acquisition of diagnostics maker Alere, with the U.S. Department of Justice signing on to a five-and-half-year-old...
www.fiercebiotech.com
Une actualité de FierceBiotech où est cité ABBOTT
Le 15/01/2019

FDA approves Abbott’s pea-sized implant for sealing congenital heart defects in premature newborns

Le 14/01/2019
Abbott has received FDA approval for its Amplatzer Piccolo Occluder, which the medtech giant describes as the world’s first implant designed for babies weighing as little as two pounds....
www.fiercebiotech.com
Une actualité de FierceBiotech où est cité ABBOTT
Le 26/06/2018

Senseonics’ recently approved implantable glucose monitor wins real-world accuracy study

Le 25/06/2018
A three-way comparison of continuous glucose monitoring devices found that Senseonics’ recently approved Eversense implantable monitor was significantly more accurate than the Dexcom G5 and the Abbott...
www.fiercebiotech.com
Charger plus d'actualités

Entreprises proposant les mêmes activités

Icone entreprise
ALSACHIM
SIGMA ALDRICH
SIGMA ALDRICH
sarl THEMIS (BIOFIDAL)
sarl THEMIS (BIOFIDAL)
EXTRASYNTHESE
EXTRASYNTHESE
MERCK MILLIPORE
MERCK MILLIPORE
Ajouter mon entreprise

Activités de l'entreprise

  • Fournisseurs matières premières Produits de synthèse pour biotechnologies

    • Adresse

    12 r de la Couture Silic 233 Rungis cdx 94528 France

    Equipes

    Je travaille dans cette entreprise